IC
TNDM icon

Innealta Capital’s Tandem Diabetes Care TNDM Stock Holding History

Innealta Capital’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-48
Closed -$1.93K – 1537
2024
Q2 		$1.93K Buy
+48
New +$2K ﹤0.01% 1104

Other funds holding TNDM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Innealta Capital's TNDM Position: Q3 2024 in Review

Innealta Capital sold out of Tandem Diabetes Care (TNDM) in Q3 2024, closing a stake of 48 shares — an estimated $1.93K sold.

Innealta Capital first reported a position in TNDM in Q2 2024 and held it in 1 quarter. The position peaked at $1.93K in Q2 2024. 332 funds tracked by Wall St. Rank hold TNDM as of Q3 2024.

  • Innealta Capital reported no remaining Tandem Diabetes Care position as of Q3 2024 after selling out during the quarter.
  • Innealta Capital sold 48 Tandem Diabetes Care shares in Q3 2024, an estimated $1.93K.
  • Innealta Capital first reported a position in Tandem Diabetes Care in Q2 2024 and held it in 1 quarter.
  • Innealta Capital's Tandem Diabetes Care position peaked at $1.93K in Q2 2024.
  • 332 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q3 2024.

Based on Innealta Capital's 13F filing for Q3 2024, filed 29 Oct 2024.